AD patients have abnormal levels of ribosomal RNAs (rRNA18S, rRNA28S), ribosomal proteins (rpS5, rpS6, rpS10, rpS13), initiation factors (eIF3eta), and elongation factors (eEF1A, eEF2), suggesting aberrant protein synthesis. The gene discussed is RPS13; the disease is Alzheimer disease.